Zimmermann Martine 4
4 · LIGAND PHARMACEUTICALS INC · Filed Sep 26, 2023
Insider Transaction Report
Form 4
Zimmermann Martine
Director
Transactions
- Award
Common Stock
2023-09-22+2,285→ 2,285 total - Award
Employee Stock Option (right to buy)
2023-09-22+11,345→ 11,345 totalExercise: $59.08Exp: 2033-09-22→ Common Stock (11,345 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on September 22, 2024; September 22, 2025; and September 22, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]Grant of Stock Options that will vest and become exercisable in three substantially equal annual installments on September 22, 2024; September 22, 2025; and September 22, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.